The survey is based on responses from 1,598 infection preventionists nationwide polled between Jan. 20 and Jan. 25. Of these respondents, 94 percent have been offered the vaccine.
A majority (85 percent) of infection preventionists said they’ve been vaccinated; 2 percent have a vaccine appointment scheduled; and 5 percent said they plan to get the vaccine later.
Seventy-two percent of infection control leaders cited the vaccine’s speed to market as the main concern contributing to vaccine hesitancy among staff members at their organization. Other reasons included fear of adverse events (60 percent), use of new vaccine technology (50 percent) and a lack of concern about getting sick from COVID-19 (24 percent).
“Clearly, the nation’s infection preventionists believe in the safety, effectiveness and necessity of COVID-19 vaccines,” the association’s President Ann Marie Pettis, RN, BSN, said in a news release. “As experts in infection prevention, IPs are in a unique position to influence and encourage vaccine uptake among other healthcare professionals and the public. If we think the vaccines are safe, we believe others should feel assured.”
More articles on infection control:
Physician viewpoint: Hospital-acquired COVID-19. is rampant, but facilities aren’t sounding the alarm
Focus on COVID-19 facilitated spread of drug-resistant infections, experts say
5 staff infected in COVID-19 outbreak at Vermont hospital’s oncology unit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
